Publications
109
Citations
1,475
Est. group size
~13
Recurring co-author estimate
Active years
19
Publishing since 2008
Sumithira Vasu's research centers on blood cancers and cellular therapies, including CAR-T cell treatments for leukemia, stem cell transplantation, and targeted drug therapies for rare blood cancers like blastic plasmacytoid dendritic cell neoplasm (BPDCN). Much of the work involves clinical trial data and real-world outcomes analysis for patients receiving these advanced treatments, including toxicity, survival, and relapse outcomes. This research is clinically oriented, often involving multi-institutional collaborations and consortiums studying treatment outcomes in adult leukemia patients.
Publication output was relatively steady over the past decade with a notable surge in 2025, suggesting an increase in recent research and clinical trial activity.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Hematopoietic effects of tagraxofusp in treatment‐naive patients with blastic plasmacytoid dendritic cell neoplasm
Cancer · 2026
- Efficacy of first-line tagraxofusp in blastic plasmacytoid dendritic cell neoplasm with prior or concomitant hematologic malignancy: subgroup analysis of a pivotal trial
Leukemia & lymphoma/Leukemia and lymphoma · 2025
- Durable post-transplant survival after first-line tagraxofusp for blastic plasmacytoid dendritic cell neoplasm
Leukemia & lymphoma/Leukemia and lymphoma · 2025
- Real-world toxicity of brexucabtagene autoleucel in adults with relapsed/refractory B-cell acute lymphoblastic leukemia
Blood Immunology & Cellular Therapy · 2025
- KMT2Ar Adversely Impacts Brexucabtagene Autoleucel (Brexu-cel) Outcome in Adults with Relapsed/ Refractory (r/r) B-Cell Acute Lymphoblastic Leukemia.
Transplantation and Cellular Therapy · 2025
- Pre- or post-CAR-T allogeneic hematopoietic cell transplant provides relapse-free survival benefit for R/R Philadelphia negative B-cell acute lymphoblastic leukemia (B-ALL) successfully treated with brexucabtagene autoleucel in the real world
Blood · 2025
- Favorable outcomes including post-transplant survival are seen independent of baseline skin burden in treatment-naïve patients (pts) with blastic plasmacytoid dendritic cell neoplasm (BPDCN) treated with tagraxofusp (TAG): Subgroup analysis of a pivotal Trial
Blood · 2025
- CAR and ALL Hematotox Scores Predict Toxicity and Outcomes Among Recipients of Brexucabtagene Autoleucel for R/R ALL in the Real World Outcomes Collaborative of CAR-T in Adult ALL (ROCCA) Consortium
Transplantation and Cellular Therapy · 2025
- A Decade of Growth in a Cell Therapy Lab at an Academic Medical Center
Cytotherapy · 2025
- Outcomes in patients (pts) younger than 50 years old (yo) with treatment-naïve blastic plasmacytoid dendritic cell neoplasm (BPDCN) treated with tagraxofusp (TAG): Subanalysis of a phase 1/2 trial.
Journal of Clinical Oncology · 2025
- POSTER: AML-1277 Anti-Tumor Activity and Restoration of Hematopoiesis Achieved With Tagraxofusp in Patients With Treatment-Naïve Blastic Plasmacytoid Dendritic Cell Neoplasm: Pivotal Trial Subanalysis
Clinical Lymphoma Myeloma & Leukemia · 2025
- AML-1277: Anti-Tumor Activity and Restoration of Hematopoiesis Achieved With Tagraxofusp in Patients With Treatment-Naïve Blastic Plasmacytoid Dendritic Cell Neoplasm: Pivotal Trial Subanalysis
Clinical Lymphoma Myeloma & Leukemia · 2025
- AML-1290: Outcomes in Patients Younger Than 50 Years Old (yo) With Treatment-Naive Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Treated With Tagraxofusp: Subanalysis of a Phase 1/2 Trial
Clinical Lymphoma Myeloma & Leukemia · 2025
- POSTER: AML-1290 Outcomes in Patients Younger Than 50 Years Old (yo) With Treatment-Naive Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Treated With Tagraxofusp: Subanalysis of a Phase 1/2 Trial
Clinical Lymphoma Myeloma & Leukemia · 2025
- Combination ruxolitinib, belumosudil, and axatilimab yields clinically significant symptomatic improvements in treatment-refractory chronic GVHD
Bone Marrow Transplantation · 2025
- Blood×25
- Transplantation and Cellular Therapy×12
- Blood Advances×5
- Journal of Clinical Oncology×4
- Haematologica×4
- Marcos J.G. De Lima
Medicine · The Ohio State University
- Gabriela Sanchez‐Petitto
Medicine · The Ohio State University
- Sumithra Vasu
Medicine · The Ohio State University
- Parvathi Ranganathan
Medicine · The Ohio State University
- Shivani Handa
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile